Inscrição na biblioteca: Guest
Critical Reviews™ in Oncogenesis

Publicou 4 edições por ano

ISSN Imprimir: 0893-9675

ISSN On-line: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Volume 21, 2016 Edição 1-2

DOI: 10.1615/CritRevOncog.v21.i1-2

Preface: The Living Legacy of Donald L. Morton Dave S.B. Hoon
pp. v-vi0
DOI: 10.1615/CritRevOncog.2016016917
Donald L. Morton, MD 1934−2014 Dave S.B. Hoon
pp. 1-2
DOI: 10.1615/CritRevOncog.2016017122
Donald L. Morton, MD.... A Legendary Surgical Oncologist and Consummate Investigator Charles M. Balch, Dave S.B. Hoon
pp. 3-5
DOI: 10.1615/CritRevOncog.2016016918
Sentinel Lymph Node Biopsy: Evolution of the Technique Since the Original Description by Morton et al. in 1992 Roger F. Uren, Omgo E. Nieweg, John F. Thompson
pp. 7-17
DOI: 10.1615/CritRevOncog.2016016916
Surgical Lymphadenectomy: The Impact of Sentinel Node Mapping in Breast Cancer Steven L. Chen
pp. 19-23
DOI: 10.1615/CritRevOncog.2016016174
A Comprehensive Approach to Pediatric Atypical Melanocytic Neoplasms with Comment on the Role of Sentinel Lymph Node Biopsy Vernon K. Sondak, Damon Reed, Jane L. Messina
pp. 25-36
DOI: 10.1615/CritRevOncog.2016016109
Metastasectomy for Stage IV Melanoma in the Era of Effective Systemic Agents David W. Ollila, Nicole E. Lopez , Eddy C. Hsueh
pp. 37-55
DOI: 10.1615/CritRevOncog.2016014729
Immunology Comes Full Circle in Melanoma While Specific Immunity Is Unleashed to Eliminate Metastatic Disease, Inflammatory Products of Innate Immunity Promote Resistance Elizabeth A. Grimm
pp. 57-63
DOI: 10.1615/CritRevOncog.2016016901
Intralesional Immunotherapy for Metastatic Melanoma: The Oldest and Newest Treatment in Oncology Mark B. Faries
pp. 65-73
DOI: 10.1615/CritRevOncog.2016017124
Therapeutic Strategies for Human IgM Antibodies Directed at Tumor-Associated Ganglioside Antigens: Discoveries Made During the Morton Era and Future Directions Peter C. Jones, Reiko F. Irie
pp. 75-81
DOI: 10.1615/CritRevOncog.2016016881
Immune Responses to BRAF-Targeted Therapy in Melanoma: Is Targeted Therapy Immunotherapy? Mark C. Kelley
pp. 83-91
DOI: 10.1615/CritRevOncog.2016017150
Hepatocellular Carcinoma: The Current Role of Surgical Intervention Steve D. Colquhoun
pp. 93-103
DOI: 10.1615/CritRevOncog.2016016116
Surgical Resection of Retroperitoneal Sarcomas: Analysis of Factors Determining Outcome Farin Amersi, Charles Forscher, Allan W. Silberman
pp. 105-113
DOI: 10.1615/CritRevOncog.2016016967
Gene Therapy for Lung Cancer Humberto Lara-Guerra, Jack A. Roth
pp. 115-124
DOI: 10.1615/CritRevOncog.2016016084
Circulating Tumor Cells in Breast Cancer Patients Carolyn Hall, Lily Valad, Anthony Lucci
pp. 125-139
DOI: 10.1615/CritRevOncog.2016016120
Liquid Biopsies for Assessing Metastatic Melanoma Progression Kelly Huynh , Dave S.B. Hoon
pp. 141-154
DOI: 10.1615/CritRevOncog.2016016075
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa Políticas de preços e assinaturas Begell House Contato Language English 中文 Русский Português German French Spain